Management of lateral pelvic lymph nodes in rectal cancer
Journal of Surgical Oncology · 2023
DOI: 10.1002/jso.27317 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Surgical Oncology, 2023. Verfasst von Gloria Chang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Surgical Oncology, Department of Surgery, University of Texas Southwestern Medical Center, Dallas, Texas, USA. Hauptthemen laut MEDLINE: Lymph Nodes, Rectal Neoplasms, Pelvis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Lateral pelvic lymph node (LPLN) involvement occurs in 10%–25% of rectal cancer cases. Total mesorectal excision (TME) with routine LPLN dissection (LPLND) is predominantly applied in Japan whereas TME with neoadjuvant treatment are used in the West. LPLND is a morbid procedure and minimally invasive techniques may help reduce its morbidity. Selective lateral pelvic node dissection with TME following neoadjuvant treatment achieves acceptable disease‐free and overall survival.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Surgical Oncology, Department of Surgery, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
- Department of Surgery, Enloe Medical Center, Chico, California, USA.
Zitieren
APA
Chang, G., Halabi, W. J., & Ali, F. (2023). Management of lateral pelvic lymph nodes in rectal cancer. Journal of Surgical Oncology. https://doi.org/10.1002/jso.27317
Vancouver
Chang G, Halabi WJ, Ali F. Management of lateral pelvic lymph nodes in rectal cancer. Journal of Surgical Oncology. 2023. doi:10.1002/jso.27317
BibTeX
@article{Chang2023,
author = {Chang, Gloria and Halabi, Wissam J and Ali, Fadwa},
title = {Management of lateral pelvic lymph nodes in rectal cancer},
journal = {Journal of Surgical Oncology},
year = {2023},
doi = {10.1002/jso.27317}
}
EUVIMED